Physician profile
Frederick Dattel
NPI 1912008525
$543.81
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $37.70 · 2021: $168 · 2022: $147.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $103.86 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.01 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $65.98 | 2021-2022 | |
| Genentech USA, INC. | $48.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $39.51 | 2019 | |
| Cranial Technologies, INC | $37.40 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $35.01 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $19.20 | 2019 | |
| Neurelis, INC. | $18.01 | 2022 | |
| Circassia INC. | $17.99 | 2019 | |
| Sanofi Pasteur INC. | $17.49 | 2019 | |
| Pfizer INC. | $15.91 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.50 | 2022 | |
| Adlon Therapeutics L.P. | $14.50 | 2020 | |
| Shire North American Group INC | $12.98 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.76 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Dattel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.